Connect Biopharma Holdings Limited (CNTB)
NASDAQ·Healthcare·Biotechnology
$2.41
-1.63%
Mkt Cap $148.14M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $538 | — | — | -$0.30 | -$0.27 | +10.00% | — | — |
| Q3 2025 Aug 13, 2025 | — | $6.70K | — | -$0.22 | -$0.23 | -4.55% | — | — |
| Q1 2025 Mar 31, 2025 | — | $261.88K | — | -$0.27 | -$0.06 | +78.66% | — | — |
| Q3 2024 Sep 5, 2024 | $2.95M | $3.32M | +12.54% | -$0.03 | $0.02 | +167.49% | — | — |
| Q2 2024 Apr 16, 2024 | $2.92M | — | — | -$0.03 | -$0.07 | -131.68% | — | — |
| Q3 2023 Sep 12, 2023 | — | — | — | -$6.92 | -$0.08 | +98.89% | — | — |
| Q2 2023 Apr 11, 2023 | — | — | — | -$3.58 | -$0.15 | +95.80% | — | — |
| Q3 2022 Sep 13, 2022 | — | — | — | -$5.28 | -$0.16 | +96.93% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | -$4.38 | -$0.17 | +96.22% | — | — |
| Q3 2021 Aug 31, 2021 | — | — | — | -$2.36 | -$0.48 | +79.66% | — | — |
| Q1 2021 Mar 19, 2021 | — | — | — | — | -$0.00 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.00 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$0.03 | — | — | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$0.03 | — | — | — |